- Home
- QNCX vs CLIR Comparison
QNCX vs CLIR Comparison
Compare QNCX & CLIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QNCX
- CLIR
- Stock Information
- Founded
- QNCX 2012
- CLIR 2008
- Country
- QNCX United States
- CLIR United States
- Employees
- QNCX N/A
- CLIR N/A
- Industry
- QNCX Biotechnology: Biological Products (No Diagnostic Substances)
- CLIR Industrial Machinery/Components
- Sector
- QNCX Health Care
- CLIR Industrials
- Exchange
- QNCX Nasdaq
- CLIR Nasdaq
- Market Cap
- QNCX 44.0M
- CLIR 30.9M
- IPO Year
- QNCX 2019
- CLIR 2012
- Fundamental
- Price
- QNCX $1.03
- CLIR $0.53
- Analyst Decision
- QNCX Strong Buy
- CLIR Strong Buy
- Analyst Count
- QNCX 5
- CLIR 1
- Target Price
- QNCX $8.00
- CLIR $2.00
- AVG Volume (30 Days)
- QNCX 511.8K
- CLIR 46.2K
- Earning Date
- QNCX 05-16-2025
- CLIR 05-21-2025
- Dividend Yield
- QNCX N/A
- CLIR N/A
- EPS Growth
- QNCX N/A
- CLIR N/A
- EPS
- QNCX N/A
- CLIR N/A
- Revenue
- QNCX N/A
- CLIR $3,596,000.00
- Revenue This Year
- QNCX N/A
- CLIR $32.84
- Revenue Next Year
- QNCX N/A
- CLIR $107.68
- P/E Ratio
- QNCX N/A
- CLIR N/A
- Revenue Growth
- QNCX N/A
- CLIR 49.65
- 52 Week Low
- QNCX $0.51
- CLIR $0.46
- 52 Week High
- QNCX $2.45
- CLIR $1.72
- Technical
- Relative Strength Index (RSI)
- QNCX 38.67
- CLIR 38.01
- Support Level
- QNCX $0.98
- CLIR $0.54
- Resistance Level
- QNCX $1.16
- CLIR $0.60
- Average True Range (ATR)
- QNCX 0.09
- CLIR 0.05
- MACD
- QNCX 0.01
- CLIR 0.01
- Stochastic Oscillator
- QNCX 22.22
- CLIR 11.33
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.
About CLIR ClearSign Technologies Corporation (DE)
ClearSign Technologies Corp is engaged in providing solutions to some of the pressing productivity, energy efficiency, and pollution problems affecting the energy, oil, and gas production, boiler, and processing industries. It believes that its patented ClearSign Core technology can enhance the performance of combustion systems in a broad range of markets, including the energy (upstream oil production and downstream refining), institutional, commercial, and industrial boiler, chemical, and petrochemical industries. The company offers products that include process burners, boiler burners, flares, and ClearSign Eye.